Helen R Gosselt (Helen Gosselt)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Top Venues

Expert opinion on drug safety

Journal of personalized medicine

Rheumatology and therapy

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Janneke M Quik, Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Peter M Ten Klooster, Harald E Vonkeman, Bartholomeus J F van den Bemt, Naomi T Jessurun
The burden of adverse drug reactions reported by patients in the Dutch ADR monitor: a proof of concept. Expert opinion on drug safety (2024)
Benthe H König, Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Bartholomeus J F van den Bemt, Peter M Ten Klooster, Harald E Vonkeman, Naomi T Jessurun
Quantification of longitudinal patient-reported burden of adverse drug reactions attributed to the use of TNF-α inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study. Expert opinion on drug safety (2024)
Helen R Gosselt, Jette A van Lint, Leanne J Kosse, Phyllis I Spuls, Harald E Vonkeman, Sander W Tas, Frank Hoentjen, Michael T Nurmohamed, Bart J F van den Bemt, Martijn Bastiaan Adriaan van Doorn, Naomi T Jessurun
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases. Expert opinion on drug safety (2023)
Renske C F Hebing, Imke H Bartelink, Helen R Gosselt, Sandra G Heil, Mauritis C F J de Rotte, Pascal H P de Jong, Mike T Nurmohamed, Robert de Jonge, Ron A A Mathôt
Methotrexate Polyglutamates Exposure - Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients starting Methotrexate. Clinical pharmacology and therapeutics (2023)
Helen R Gosselt, Elizabeth A Bazelmans, Thomas Lieber, Florence P A M van Hunsel, Linda Härmark
Development of a multivariate prediction model to identify individual case safety reports which require clinical review. Pharmacoepidemiology and drug safety 31 (12) (2022)
Helen R Gosselt, Maxime M A Verhoeven, Maja Bulatović-Ćalasan, Paco M Welsing, Maurits C F J de Rotte, Johanna M W Hazes, Floris P J G Lafeber, Mark Hoogendoorn, Robert de Jonge
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis. Journal of personalized medicine 11 (1) (2021)
Helen R Gosselt, Costanza L Vallerga, Pooja R Mandaviya, Erik Lubberts, Johanna M W Hazes, Robert de Jonge, Sandra G Heil
Epigenome wide association study of response to methotrexate in early rheumatoid arthritis patients. PloS one 16 (3) (2021)
Helen R Gosselt, Maxime M A Verhoeven, Maurits C F J de Rotte, Saskia M F Pluijm, Ittai B Muller, Gerrit Jansen, Janneke Tekstra, Maja Bulatović-Ćalasan, Sandra G Heil, Floris P J G Lafeber, Johanna M W Hazes, Robert de Jonge
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio. Rheumatology and therapy 7 (4) (2020)
Helen R Gosselt, Pieter H Griffioen, Bertrand D van Zelst, Natanja Oosterom, Robert de Jonge, Sandra G Heil
Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures. Epigenetics 16 (1) (2020)
Helen R Gosselt, Ittai B Muller, Gerrit Jansen, Michel van Weeghel, Frederic M Vaz, Johanna M W Hazes, Sandra G Heil, Robert de Jonge
Identification of Metabolic Biomarkers in Relation to Methotrexate Response in Early Rheumatoid Arthritis. Journal of personalized medicine 10 (4) (2020)